20 September 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada ...
12 September 2023 - Paladin Labs announced today that CADTH has recommended that Xcopri (cenobamate) be publicly reimbursed as adjunctive therapy ...
29 August 2023 - Mitsubishi Tanabe Pharma Canada today announced that Radicava oral suspension (edaravone) is now covered under the New ...
18 August 2023 - CADTH is establishing an industry task force that will build upon the recently released guidance for reporting ...
24 August 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada has ...
22 August 2023 - The Patented Medicine Prices Review Board published today the 7th edition of its annual Meds Entry Watch ...
17 August 2023 - This is the first public listing since Minjuvi was approved with conditions by Health Canada in ...
7 August 2023 - People diagnosed with ALS are usually given two to five years to live. ...
2 August 2023 - Jazz Pharmaceuticals today announced that the Company has entered into a letter of intent with the pan-Canadian ...
24 July 2023 - New Brunswick lists Albrioza on its drug benefit formulary, becoming the fourth province to provide public ...
19 July 2023 - Amylyx Pharmaceuticals Canada announced today that the Company has entered into a Product Listing Agreement with British ...
23 July 2023 - $6 million USD in funding will help address health disparities among indigenous communities with a focus ...
20 July 2023 - As CADTH continues along the path of strategic transformation, we’re working hard to align the evidence products ...
12 July 2023 - Duchesnay is pleased to announce that Slynd (drospirenone 4 mg), used to prevent pregnancy in girls ...
11 July 2023 - Médunik Canada is pleased to announce that Ruzurgi (amifampridine) is now covered by the vast majority of ...